Inibidores de CDK4/6 no câncer de mama HR+/HER2-

CME

Especialistas respondem às suas perguntas sobre inibidores de CDK4/6 no câncer de mama HR+/HER2-

ABPath Shiv Test

AMA shiv test

Released: August 19, 2024

Expiration: August 18, 2025

Sara A. Hurvitz
Sara A. Hurvitz, MD, FACP
Erica L. Mayer
Erica L. Mayer, MD, MPH
Joyce O'Shaughnessy
Joyce O'Shaughnessy, MD

Activity

Progress
1 2
Course Completed